4//SEC Filing
Smith Mark Alan 4
Accession 0001415889-21-003388
CIK 0001411685other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:11 PM ET
Size
4.8 KB
Accession
0001415889-21-003388
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2021-06-30$1.95/sh+2,260$4,399→ 12,260 total
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001677452
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:11 PM ET
- Size
- 4.8 KB